TAVR is a minimally invasive valve replacement procedure that replaces a diseased aortic heart valve without open-heart surgery using a balloon expandable valve that is inserted through a small incision in the groin. The procedure takes approximately 2 hours.
During the procedure, the artificial valve – framed by a stent and wrapped around a balloon – is transported up to the aortic valve via a large catheter in the leg. The new valve is then anchored into position inside the diseased valve by inflation of a balloon. Placement of the stent is monitored with X-ray and ultrasound imaging.
Interventional cardiologists and UF Health cardiothoracic surgeons work together in our hybrid imaging and surgery operating room to perform this innovative procedure.
This procedure is used for select patients with severe symptomatic aortic stenosis (narrowing of the aortic valve opening) who are intermediate, high risk, or in-operable candidates for traditional open heart surgery.
After surgery, you will recover overnight in Cardiovascular ICU. From CVICU, you will transfer to a step down unit in the Cardiac Progressive Care Unit (CPCU) or Cardiac Intermediate Care Unit (CIC) until discharge, typically within 1-3 days.
TAVR benefits may include:
Halifax Health has collaborated with University of Florida Health (UF Health) to bring advanced thoracic, cardiovascular and vascular surgical care to Volusia, Flagler and Brevard Counties. Board-certified and fellowship-trained cardiothoracic and vascular surgeons from UF Health lead the program and are located at the main campus of Halifax Health in Daytona Beach, Florida.
Halifax Health serves as the areas only Level II Trauma Center and through this partnership with UF Health we can now expand on the services available to our community.
For more information or to make an appointment, please contact Kristin Hosterman, RN, TAVR Coordinator, or Jennifer Adamy, BSN RN, TAVR Coordinator, at 386.425.7218.
